Literature DB >> 486161

The vectorial orientation of human monoamine oxidase in the mitochondrial outer membrane.

S M Russell, J Davey, R J Mayer.   

Abstract

1. The localization of monoamine oxidase in the mitochondrial outer membrane was studied in preparations of human liver mitochondrial and brain-cortex non-synaptosomal and synaptosomal mitochondria. 2. Immunochemical accessibility in iso-osmotic and hypo-osmotic mitochondrial preparations was used to localize the enzyme. 3. It was shown that the immunochemically accessible tyramine-oxidizing activity was distributed approximately equally on both surfaces of the membrane in human liver and brain-cortex non-synaptosomal mitochondria. However, the immunochemically accessible beta-phenethylamine-oxidizing activity was situated predominantly on the outer surface, and the immunochemically accessible 5-hydroxytryptamine-oxidizing activity was situated predominantly on the inner surface of the mitochondrial outer membrane in liver and brain-cortex non-synaptosomal mitochondrial preparations. 4. Considerable variation in the distribution of the enzyme in preparations of synaptosomal mitochondria was seen. 5. The simplest model consistent with our observations is that, in liver and brain-cortex non-synaptosomal mitochondria, the tyramine-oxidizing activity is distributed on both sides of the mitochondrial outer membrane, the beta-phenethylamine-oxidizing activity is located on the outer surface of the outer membrane and the 5-hydroxytryptamine-oxidizing activity is located on the inner surface of the mitochondria outer membrane.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 486161      PMCID: PMC1161119          DOI: 10.1042/bj1810007

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  22 in total

1.  Biochemistry of dystrophic muscle. Mitochondrial succinate-tetrazolium reductase and adenosine triphosphatase.

Authors:  R J PENNINGTON
Journal:  Biochem J       Date:  1961-09       Impact factor: 3.857

2.  The histochemical demonstration of monoamine oxidase activity by tetrazolium salts.

Authors:  G G GLENNER; H J BURTNER; G W BROWN
Journal:  J Histochem Cytochem       Date:  1957-11       Impact factor: 2.479

3.  Kinetics of binding of cytochrome c oxidase from rat liver to an immunoadsorbent [proceedings].

Authors:  J H Walker; R J Mayer
Journal:  Biochem Soc Trans       Date:  1977       Impact factor: 5.407

4.  The localization of amine oxidase in the liver cell.

Authors:  J HAWKINS
Journal:  Biochem J       Date:  1952-03       Impact factor: 3.857

5.  Some kinetic and inhibition properties of human brain mitochondrial monoamine oxidase (EC 1.4.3.4).

Authors:  M Jain; E Bakutis; T Gayle; P Lansky
Journal:  Neurobiology       Date:  1974

6.  Allotopic properties of human brain monoamine oxidase.

Authors:  K F Tipton; M D Houslay; N J Garrett
Journal:  Nat New Biol       Date:  1973-12-19

7.  Bovine liver monoamine oxidase. A modified purification procedure and preliminary evidence for two subunits and one FAD.

Authors:  N Minamiura; K T Yasunobu
Journal:  Arch Biochem Biophys       Date:  1978-08       Impact factor: 4.013

8.  Multiple binding sites of human brain and liver monoamine oxidase: substrate specificities, selective inhibitions, and attempts to separate enzyme forms.

Authors:  H L White; A T Glassman
Journal:  J Neurochem       Date:  1977-12       Impact factor: 5.372

Review 9.  Membrane asymmetry.

Authors:  J E Rothman; J Lenard
Journal:  Science       Date:  1977-02-25       Impact factor: 47.728

10.  Purification and immunochemical characterization of monoamine oxidase from rat and human liver.

Authors:  R G Dennick; R J Mayer
Journal:  Biochem J       Date:  1977-01-01       Impact factor: 3.857

View more
  9 in total

1.  Immunochemical characterization of monoamine oxidase from human liver, placenta, platelets and brain cortex.

Authors:  S M Russell; J Davey; R J Mayer
Journal:  Biochem J       Date:  1979-07-01       Impact factor: 3.857

2.  Translocation to rat liver mitochondria of phosphatidate phosphohydrolase.

Authors:  M Freeman; E H Mangiapane
Journal:  Biochem J       Date:  1989-10-15       Impact factor: 3.857

3.  Topological probes of monoamine oxidases A and B in rat liver mitochondria: inhibition by TEMPO-substituted pargyline analogues and inactivation by proteolysis.

Authors:  Jin Wang; Dale E Edmondson
Journal:  Biochemistry       Date:  2011-03-07       Impact factor: 3.162

4.  Monoamine oxidases A and B are differentially regulated by glucocorticoids and "aging" in human skin fibroblasts.

Authors:  S B Edelstein; X O Breakefield
Journal:  Cell Mol Neurobiol       Date:  1986-06       Impact factor: 5.046

5.  Development of spin-labeled pargyline analogues as specific inhibitors of human monoamine oxidases A and B.

Authors:  Anup K Upadhyay; Dale E Edmondson
Journal:  Biochemistry       Date:  2009-05-12       Impact factor: 3.162

6.  Monoclonal antibodies to monoamine oxidase B and another mitochondrial protein from human liver.

Authors:  E E Billett; R J Mayer
Journal:  Biochem J       Date:  1986-04-01       Impact factor: 3.857

7.  Comparison of the degradative fate of monoamine oxidase in endogenous and transplanted mitochondrial outer membrane in rat hepatocytes. Implications for the cytomorphological basis of protein catabolism.

Authors:  P J Evans; R J Mayer
Journal:  Biochem J       Date:  1984-04-01       Impact factor: 3.857

8.  A cytochrome c is the natural electron acceptor for nicotine oxidoreductase.

Authors:  Mark Dulchavsky; Christopher T Clark; James C A Bardwell; Frederick Stull
Journal:  Nat Chem Biol       Date:  2021-01-11       Impact factor: 15.040

9.  Preferential Extracellular Generation of the Active Parkinsonian Toxin MPP+ by Transporter-Independent Export of the Intermediate MPDP+.

Authors:  Stefan Schildknecht; Regina Pape; Johannes Meiser; Christiaan Karreman; Tobias Strittmatter; Meike Odermatt; Erica Cirri; Anke Friemel; Markus Ringwald; Noemi Pasquarelli; Boris Ferger; Thomas Brunner; Andreas Marx; Heiko M Möller; Karsten Hiller; Marcel Leist
Journal:  Antioxid Redox Signal       Date:  2015-11-01       Impact factor: 8.401

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.